Topic: ulcerative colitis
Merck KGaA spinoff Calypso Biotech has licensed its inflammatory bowel disease candidate to EA Pharma, a joint venture between Eisai and Ajinomoto.
After its $7.2 billion buyout of Receptos, Celgene has posted some encouraging midstage data for its acquired asset ozanimod for certain forms of inflammatory bowel disease.
Gilead said in a brief update that it will be canning its combined Phase II/III test of its experimental GI med GS-5745 after finding that there was “insufficient evidence of a treatment benefit” in those taking the drug.
Takeda announced on Wednesday that it is partnering with Vanderbilt University and Texas Digestive Disease Consultants on a digital program to help patients and physicians manage inflammatory bowel disease.
Shire has bought the rights to Pfizer’s experimental midstage inflammatory bowel disease drug PF-00547659 as it looks to shore up its own GI portfolio.